59% of buyers regret at least one software purchase made in the past 18 months, according to a 2025 Gartner report on software buying trends.
In life sciences, the wrong biotech procurement software doesn’t just waste budget. It slows research, creates workarounds, and frustrates everyone from scientists to finance teams.
With so many platforms claiming to streamline purchasing, how do you know which one will actually deliver?
This guide shares seven key questions to help you evaluate biotech procurement solutions
In a landscape where nearly 60% of buyers regret recent software decisions, it's clear that due diligence matters more than ever, especially in biotech procurement, where mistakes can slow down science.
The right solution shouldn't just streamline ordering. It should eliminate silos, connect systems, and give labs the visibility, flexibility, and control they need to operate efficiently. It's time to move beyond patchwork fixes and choose technology that actively propels your research forward.